[
  {
    "ts": null,
    "headline": "Eli Lilly Pops After Biden Proposes Medicare Cover Obesity Drugs. Is Lilly Stock A Buy?",
    "summary": "Eli Lilly stock popped on news President Joe Biden proposed Medicare and Medicaid pay for weight-loss drugs. Is LLY stock a buy?",
    "url": "https://finnhub.io/api/news?id=90d8ab6a663f1a994b23b9c09a625d8f05ca9331088afe822a86415b9c96b7a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732649022,
      "headline": "Eli Lilly Pops After Biden Proposes Medicare Cover Obesity Drugs. Is Lilly Stock A Buy?",
      "id": 131652333,
      "image": "",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Eli Lilly stock popped on news President Joe Biden proposed Medicare and Medicaid pay for weight-loss drugs. Is LLY stock a buy?",
      "url": "https://finnhub.io/api/news?id=90d8ab6a663f1a994b23b9c09a625d8f05ca9331088afe822a86415b9c96b7a8"
    }
  },
  {
    "ts": null,
    "headline": "Cassana Sciences collapsed after study disappointment in Alzheimer's",
    "summary": "Cassava Sciences' Phase 3 study of the drug candidate simufilam in patients with mild to moderate Alzheimer's disease , has shown no significant reduction in cognitive or functional impairment...",
    "url": "https://finnhub.io/api/news?id=0f805b1ac0a71a69171acce36f1e42cb94d695402fe409b612b8abecb4f20312",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732588581,
      "headline": "Cassana Sciences collapsed after study disappointment in Alzheimer's",
      "id": 131629376,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "Cassava Sciences' Phase 3 study of the drug candidate simufilam in patients with mild to moderate Alzheimer's disease , has shown no significant reduction in cognitive or functional impairment...",
      "url": "https://finnhub.io/api/news?id=0f805b1ac0a71a69171acce36f1e42cb94d695402fe409b612b8abecb4f20312"
    }
  },
  {
    "ts": null,
    "headline": "Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the \"AD-DMT Registry\" in Japan",
    "summary": "- Eisai Co., Ltd. and Biogen Japan Ltd. announced today that Eisai has entered into a research collaboration agreement with the National Center of Neurology and Psychiatry to conduct apolipoprotein E ...",
    "url": "https://finnhub.io/api/news?id=4c7624c94064ad774c3a8245d50130c895cfaad1b41a59d2f8a5d76ef143c9a5",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732587125,
      "headline": "Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the \"AD-DMT Registry\" in Japan",
      "id": 131629239,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "- Eisai Co., Ltd. and Biogen Japan Ltd. announced today that Eisai has entered into a research collaboration agreement with the National Center of Neurology and Psychiatry to conduct apolipoprotein E ...",
      "url": "https://finnhub.io/api/news?id=4c7624c94064ad774c3a8245d50130c895cfaad1b41a59d2f8a5d76ef143c9a5"
    }
  }
]